Results of Phase I Clinical Study of Qilu Pharma’s PD-1/CTLA-4 Bifunctional Antibody Iparomlimab/Tuvonralimab Published Online in Journal of Hematology & Oncology USA – English APAC – English

JINAN, China, May 12, 2023 /PRNewswire/ — On May 8, 2023, Journal of Hematology & Oncology (JHO, 2022 impact factor of 23.168) published the results of the Phase I clinical study of Qilu Pharma’s immunotherapy bifunctional antibody, QL1706 (J Hematol Oncol. 2023 May 8;16(1):50). This study is the first large Phase I clinical trial of … Read more

Bio 9 Ventures Healthcare IT division, Tekwings Data Platforms division, Cloud N Cluster and Santanish have entered into a definitive merger agreement to form a new business called Kanectify that will add end-to-end integrated benefits to Platform Engineering, AI Healthcare and portfolio of Digital Health R&D Solutions

DALLAS, May 12, 2023 /PRNewswire/ — Texas based Bio 9 Ventures, a boutique healthcare ecosystem strategic and consulting firm, today announces the merger of its international healthcare IT division with data platforms division of Tekwings, an integrated IT engineering company with offices all around the world that supports product engineering, platform engineering and operational R&D … Read more

Children’s Minnesota opens new specialty center in Maple Grove

MINNEAPOLIS and ST. PAUL, Minn., May 12, 2023 /PRNewswire/ — Children’s Minnesota is pleased to announce it has opened a second location for specialty care services in Maple Grove. The Children’s Minnesota Primary Care and Specialty Center – Maple Grove (Bass Lake Road) is located in the same building next to our existing Partners in … Read more

Laboratory analytical instruments and consumables market size to grow by USD 15.99 billion from 2022 to 2027, The high prevalence of infectious diseases to drive the market growth

NEW YORK, May 12, 2023 /PRNewswire/ — The global laboratory analytical instruments and consumables market size is estimated to increase by USD 15.99 billion from 2022 to 2027. The market’s growth momentum will progress at a CAGR of 8.41% during the forecast period. The high prevalence of infectious diseases significantly drives the laboratory analytical instruments and consumables market growth. The … Read more

world’s first recyclable vape by Flonq debuts in the UK

LONDON, May 12, 2023 /PRNewswire/ — Vape manufacturer Flonq has today launched the world’s first fully recyclable vape device – the Flonq Plus-E at the Vaper Expo in Birmingham, the leading industry event in Europe. The innovative e-cigarette addresses two major challenges in the vaping industry: preventing minors from accessing devices and reducing environmentally harmful … Read more

DanCann Pharma A/S publishes Annual Report 2022

COPENHAGEN, Denmark, May 12, 2023 /PRNewswire/ — DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) (“DanCann Pharma” or the “Company”), a Danish company powered by cannabinoids, hereby announce that The Board of Directors and the Chief Executive Officer of DanCann Pharma publishes the annual report of the year 2022. The annual report is available in this press … Read more

INTERIM REPORT FIRST QUARTER 2023

GOTHENBURG, Sweden, May 12, 2023 /PRNewswire/ — HIGH SALES GROWTH AND STRONG PROFITABILITY IN THE FIRST QUARTER Revenues during the first quarter of 2023 amounted to SEK 393.7 (334.4) million, which corresponded to 18% (0%) growth compared to the corresponding period last year. EBITDA increased to SEK 44.4 (25.8) million and the EBITDA margin increased … Read more

Implantica publishes Interim Report January

RefluxStop™ – Designed for a Revolution in the Care of Acid Reflux VADUZ, Liechtenstein, May 12, 2023 /PRNewswire/ — Significant events in the first quarter of 2023            RefluxStop™ is currently being launched in Scandinavia, with Ersta Hospital and Sundsvall Sjukhus in Sweden, the first centers committing to join our registry study.          … Read more

Invivoscribe annonce l’approbation IVDR du test de mutation FLT3 LeukoStrat CDx

SAN DIEGO, 12 mai 2023 /PRNewswire/ — « Aujourd’hui, nous sommes heureux d’annoncer que le test de mutation FLT3 LeukoStrat® CDx d’Invivoscribe a été approuvé par BSI (Pays-Bas) et l’EMA en tant que test CDx de classe C, répondant aux nouvelles exigences rigoureuses de l’IVDR (règlement (UE) 2017/746). Invivoscribe est l’une des premières sociétés au monde à obtenir une approbation IVDR … Read more

Nippon Express Italia obtiene la certificación IATA CEIV Pharma

– Nippon Express Italia obtiene la certificación IATA CEIV Pharma para su instalación cerca del aeropuerto de Milán Malpensa TOKIO, 12 de mayo de 2023 /PRNewswire/ — Nippon Express Italia S.p.A. (en adelante, “NX Italia”), empresa del grupo NIPPON EXPRESS HOLDINGS, INC., ha adquirido la certificación IATA CEIV Pharma*, un certificado de calidad para el transporte … Read more